Loading...
XSHE300049
Market cap1.12bUSD
Jan 14, Last price  
32.32CNY
1D
2.34%
1Q
-32.26%
Jan 2017
54.27%
IPO
223.85%
Name

Inner Mongolia Furui Medical Science Co Ltd

Chart & Performance

D1W1MN
XSHE:300049 chart
P/E
80.63
P/S
7.10
EPS
0.40
Div Yield, %
0.65%
Shrs. gr., 5y
-0.70%
Rev. gr., 5y
5.88%
Revenues
1.15b
+14.37%
121,590,130126,413,281141,257,489179,975,339210,246,377301,658,211407,639,040523,483,188645,517,669604,191,265826,987,166849,675,042867,029,327831,739,342807,532,608898,483,2281,008,765,8621,153,733,886
Net income
102m
+3.75%
22,608,68522,476,59925,816,98434,418,07446,853,13852,490,69641,137,5394,905,38587,235,29591,685,239121,047,92971,866,91035,416,10143,385,84961,905,64095,468,87897,889,810101,563,741
CFO
305m
+60.92%
49,515,95717,846,52336,473,049049,198,38275,751,89285,883,73228,183,17150,875,669158,159,638148,843,876126,160,83478,347,686256,227,191200,151,631208,310,758189,461,778304,889,062
Dividend
Jun 13, 20230.2 CNY/sh
Earnings
May 21, 2025

Profile

Inner Mongolia Furui Medical Science Co., Ltd. operates as a professional medical service platform company. The company provides disease diagnosis, drug treatment, and chronic disease management products in the liver disease field. It also offers health management center and medical care services. The company was formerly known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company. Inner Mongolia Furui Medical Science Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.
URL
http://www.fu-rui.com/
IPO date
Jan 20, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,153,734
14.37%
1,008,766
12.27%
Cost of revenue
551,004
671,982
Unusual Expense (Income)
NOPBT
602,730
336,784
NOPBT Margin
52.24%
33.39%
Operating Taxes
58,286
46,253
Tax Rate
9.67%
13.73%
NOPAT
544,444
290,532
Net income
101,564
3.75%
97,890
2.54%
Dividends
(53,418)
Dividend yield
0.47%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
13,842
Long-term debt
89,805
83,667
Deferred revenue
403,917
401,975
Other long-term liabilities
50,312
14,300
Net debt
(642,639)
(618,894)
Cash flow
Cash from operating activities
304,889
189,462
CAPEX
(189,228)
Cash from investing activities
(150,425)
Cash from financing activities
(137,144)
FCF
528,484
205,469
Balance
Cash
603,700
615,411
Long term investments
128,743
100,993
Excess cash
674,757
665,966
Stockholders' equity
1,484,773
1,463,198
Invested Capital
1,671,754
1,588,358
ROIC
33.40%
19.04%
ROCE
25.66%
14.93%
EV
Common stock shares outstanding
263,050
263,053
Price
43.59
78.43%
24.43
66.19%
Market cap
11,466,365
78.43%
6,426,387
68.33%
EV
11,123,782
6,087,902
EBITDA
683,628
409,176
EV/EBITDA
16.27
14.88
Interest
1,425
1,584
Interest/NOPBT
0.24%
0.47%